49 studies found for:    "Kennedy disease"
Show Display Options
Rank Status Study
21 Recruiting A Safety Study of JNJ-56021927 in Participants With Metastatic Castration-Resistant Prostate Cancer
Condition: Prostatic Neoplasms, Castration-Resistant
Intervention: Drug: JNJ-56021927
22 Suspended A Phase 1a/1b Study to Evaluate the Safety of EZN-4176, in Adult Patients With Castration-Resistant Prostate Cancer
Condition: Prostatic Neoplasm
Intervention: Drug: EZN-4176
23 Not yet recruiting Androgen Deprivation Therapy in Advanced Salivary Gland Cancer
Condition: Salivary Gland Cancer
Interventions: Drug: bicalutamide + triptorelin;   Drug: Cisplatin + Doxorubicin;   Drug: Carboplatin + Paclitaxel
24 Recruiting Sodium Fluoride (NaF) Positron Emission Tomography/Computed Tomography (PET/CT) in Patients With Metastatic Castrate-resistant Prostate Cancer (CRPC) With Microtubule Directed Chemo or AR-directed Therapy
Condition: Prostate Cancer
Intervention: Procedure: Sodium Fluoride (NaF) Positron Emission Tomography/Computed Tomography (PET/CT) imaging
25 Recruiting CR1447 in Endocrine Responsive-HER2neg and TN-ARpos Breast Cancer
Conditions: Metastatic Breast Adenocarcinoma;   Breast Cancer
Intervention: Drug: CR1447
26 Completed Gene Mutations in Patients With Advanced Prostate Cancer That Is Not Responsive to Hormone Therapy
Condition: Prostate Cancer
Intervention: Genetic: mutation analysis
27 Recruiting AR and ER Imaging in Metastatic Breast Cancer
Condition: Metastatic Breast Cancer
Interventions: Other: FDHT-PET scan;   Other: FES-PET scan;   Other: CT-scan;   Other: Bone scintigraphy;   Other: Tumor biopsy
28 Unknown  Biomarkers in Bone Marrow and Blood Samples From Patients With Prostate Cancer Treated With Ketoconazole
Condition: Prostate Cancer
Interventions: Genetic: gene expression analysis;   Genetic: microarray analysis;   Genetic: protein analysis;   Genetic: reverse transcriptase-polymerase chain reaction;   Other: immunohistochemistry staining method;   Other: laboratory biomarker analysis;   Other: mass spectrometry
29 Active, not recruiting Bicalutamide With or Without Akt Inhibitor MK2206 in Treating Patients With Previously Treated Prostate Cancer
Conditions: Recurrent Prostate Cancer;   Stage I Prostate Cancer;   Stage IIA Prostate Cancer;   Stage IIB Prostate Cancer;   Stage III Prostate Cancer
Interventions: Drug: Akt inhibitor MK2206;   Drug: bicalutamide;   Other: clinical observation
30 Terminated
Has Results
DHEA in Treating Women Undergoing Surgery for Stage I, Stage II, or Stage III Breast Cancer
Condition: Breast Cancer
Interventions: Drug: DHEA;   Procedure: Surgical resection
31 Active, not recruiting The Effect of Hormonal Contraception on Female
Condition: Adverse Effect of Oral Contraceptives, Initial Encounter
Interventions: Other: Contraceptives, Oral, Combined;   Other: Controls
32 Completed Mifepristone (RU-486) in Androgen Independent Prostate Cancer
Conditions: Prostate Cancer;   Adenocarcinoma of Prostate
Intervention: Drug: Mifepristone
33 Active, not recruiting Abiraterone Acetate Combined With Dutasteride for Metastatic Castrate Resistant Prostate Cancer
Condition: Prostate Cancer
Interventions: Drug: Abiraterone acetate;   Drug: Dutasteride;   Drug: Prednisone
34 Active, not recruiting Androgen Deprivation Therapy and Vorinostat Followed by Radical Prostatectomy in Treating Patients With Localized Prostate Cancer
Conditions: Adenocarcinoma of the Prostate;   Stage I Prostate Cancer;   Stage IIA Prostate Cancer;   Stage IIB Prostate Cancer;   Stage III Prostate Cancer
Interventions: Drug: bicalutamide;   Drug: leuprolide acetate;   Drug: goserelin acetate;   Drug: vorinostat;   Procedure: therapeutic conventional surgery;   Other: laboratory biomarker analysis
35 Active, not recruiting Phase II Study of GTx024 in Women With Metastatic Breast Cancer
Condition: Metastatic Breast Cancer
Intervention: Drug: GTx-024 9mg
36 Withdrawn Bicalutamide With or Without Enzastaurin in Treating Patients With Prostate Cancer
Condition: Prostate Cancer
Interventions: Drug: bicalutamide;   Drug: enzastaurin hydrochloride
37 Recruiting Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics Study of GSK2881078 in Single and Repeat Doses
Condition: Cachexia
Interventions: Drug: GSK2881078;   Drug: Placebo
38 Active, not recruiting Bicalutamide in Treating Patients With Metastatic Breast Cancer
Condition: Breast Cancer
Interventions: Drug: bicalutamide;   Other: diagnostic laboratory biomarker analysis;   Other: immunohistochemistry staining method
39 Recruiting Abiraterone Acetate in Treating Postmenopausal Women With Advanced or Metastatic Breast Cancer
Condition: Breast Cancer
Interventions: Drug: abiraterone acetate;   Other: laboratory biomarker analysis;   Other: pharmacogenomic studies
40 Completed A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of GSK2849466 in Healthy Male Subjects
Condition: Cachexia
Interventions: Drug: GSK2849466;   Drug: Placebo

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-49) Show next page of results
Indicates status has not been verified in more than two years